laminin Search Results


99
Developmental Studies Hybridoma Bank mhc isoforms
Mhc Isoforms, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mhc isoforms/product/Developmental Studies Hybridoma Bank
Average 99 stars, based on 1 article reviews
mhc isoforms - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

96
AMS Biotechnology laminin 511 e8 fragment
Laminin 511 E8 Fragment, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/laminin 511 e8 fragment/product/AMS Biotechnology
Average 96 stars, based on 1 article reviews
laminin 511 e8 fragment - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

94
Trevigen laminin i
Laminin I, supplied by Trevigen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/laminin i/product/Trevigen
Average 94 stars, based on 1 article reviews
laminin i - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology laminin
Figure 5. Human PDLSCs cultured on TEST titanium implant surface were observed after 8 weeks of incubation. Cytoskeleton actin was stained in red fluorescence; specific markers <t>(A)</t> <t>Fibronectin.</t> This picture was taken from the paper published [14]. (B) <t>Laminin,</t> (C) N-cadherin and (D) RUNX2, were stained in green fluorescence; nuclei were stained in blue fluorescence. Scale bar: 10 µm.
Laminin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/laminin/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
laminin - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

95
Novus Biologicals anti laminin
Figure 5. Human PDLSCs cultured on TEST titanium implant surface were observed after 8 weeks of incubation. Cytoskeleton actin was stained in red fluorescence; specific markers <t>(A)</t> <t>Fibronectin.</t> This picture was taken from the paper published [14]. (B) <t>Laminin,</t> (C) N-cadherin and (D) RUNX2, were stained in green fluorescence; nuclei were stained in blue fluorescence. Scale bar: 10 µm.
Anti Laminin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti laminin/product/Novus Biologicals
Average 95 stars, based on 1 article reviews
anti laminin - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

93
Proteintech anti lamr1
Figure 5. Human PDLSCs cultured on TEST titanium implant surface were observed after 8 weeks of incubation. Cytoskeleton actin was stained in red fluorescence; specific markers <t>(A)</t> <t>Fibronectin.</t> This picture was taken from the paper published [14]. (B) <t>Laminin,</t> (C) N-cadherin and (D) RUNX2, were stained in green fluorescence; nuclei were stained in blue fluorescence. Scale bar: 10 µm.
Anti Lamr1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti lamr1/product/Proteintech
Average 93 stars, based on 1 article reviews
anti lamr1 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
R&D Systems anti laminin 5 antibody
Figure 5. Human PDLSCs cultured on TEST titanium implant surface were observed after 8 weeks of incubation. Cytoskeleton actin was stained in red fluorescence; specific markers <t>(A)</t> <t>Fibronectin.</t> This picture was taken from the paper published [14]. (B) <t>Laminin,</t> (C) N-cadherin and (D) RUNX2, were stained in green fluorescence; nuclei were stained in blue fluorescence. Scale bar: 10 µm.
Anti Laminin 5 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti laminin 5 antibody/product/R&D Systems
Average 93 stars, based on 1 article reviews
anti laminin 5 antibody - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Bioss antibodies against laminin α5
Mice bearing Cer2-OVA MMTV-PyMT lung metastases were treated with vehicle (0.5% HPMC) or 75 mg/kg VS-4718 p.o. for 2 weeks starting 4 weeks post-implantation. ( A & B ) Representative images and quantification of collagen VIIIα1 and <t>laminin</t> 5α in metastatic versus non-metastatic lung regions at 6 weeks (H-score; each dot represents one lesion; n = <t>5</t> mice/group). Kruskal-Wallis test and Dunn’s multiple comparison. ( C & D ) Collagen VIIIα1 and laminin 511 suppress CD8⁺ T cell activation in vitro . CD8⁺ T cells were plated on 1 μg/mL ECM components, stimulated with CD3/CD28 + IL-2 for 48 h, and assessed by flow cytometry for CD25, granzyme B, IFNγ, and TNFα expression (n = 3-5). ( E ) ECM-mediated inhibition of CD8⁺ T cell migration. Transwell inserts coated with laminin 511, or collagen VIIIα were used to assess migration toward serum-rich media for 5 h (n = 3-4). ( F ) ECM-dependent CD8⁺ T cell adhesion. Adhesion to laminin 511, or collagen VIIIα-coated plates was quantified after 90 min and normalized to uncoated plates (n = 3-4). (G & H) Kaplan-Meier curves showing progression-free survival (PFS) of patients with invasive breast carcinoma stratified by (G) COL8A1 and (H) LAMA5 expression levels. Patients were divided into high and low expression groups based on the median RNA-seq expression. Point-wise z-test using Greenwood’s standard error. Data source = Breast invasive carcinoma TCGA. ( I-K ) Spearman’s Correlation of Metastatic burden signature correlated to FAK-dependent ECM score (I ), COL8A1 ( J ) and LAMA5 ( K ) expression in triple negative breast cancer patients of the SCAN-B dataset . Spearman’s correlation of cytotoxic CD8 + T cells with COL8A1 ( L ) and LAMA5 ( M ) expression in triple negative breast cancer patients of the SCAN-B dataset. ( L & M ). Log 2 mRNA abundance of COL8A1 and LAMA5 in triple negative breast cancer patients with complete response (pCR) or residual disease (RD) in biopsies taken before treatment with either Palclitaxel and Pembrolizumab ( O ) or Palclitaxel, ABT888 and Carboplatin ( N ) in ISPY-2 trial.
Antibodies Against Laminin α5, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against laminin α5/product/Bioss
Average 90 stars, based on 1 article reviews
antibodies against laminin α5 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

94
Developmental Studies Hybridoma Bank laminin
Mice bearing Cer2-OVA MMTV-PyMT lung metastases were treated with vehicle (0.5% HPMC) or 75 mg/kg VS-4718 p.o. for 2 weeks starting 4 weeks post-implantation. ( A & B ) Representative images and quantification of collagen VIIIα1 and <t>laminin</t> 5α in metastatic versus non-metastatic lung regions at 6 weeks (H-score; each dot represents one lesion; n = <t>5</t> mice/group). Kruskal-Wallis test and Dunn’s multiple comparison. ( C & D ) Collagen VIIIα1 and laminin 511 suppress CD8⁺ T cell activation in vitro . CD8⁺ T cells were plated on 1 μg/mL ECM components, stimulated with CD3/CD28 + IL-2 for 48 h, and assessed by flow cytometry for CD25, granzyme B, IFNγ, and TNFα expression (n = 3-5). ( E ) ECM-mediated inhibition of CD8⁺ T cell migration. Transwell inserts coated with laminin 511, or collagen VIIIα were used to assess migration toward serum-rich media for 5 h (n = 3-4). ( F ) ECM-dependent CD8⁺ T cell adhesion. Adhesion to laminin 511, or collagen VIIIα-coated plates was quantified after 90 min and normalized to uncoated plates (n = 3-4). (G & H) Kaplan-Meier curves showing progression-free survival (PFS) of patients with invasive breast carcinoma stratified by (G) COL8A1 and (H) LAMA5 expression levels. Patients were divided into high and low expression groups based on the median RNA-seq expression. Point-wise z-test using Greenwood’s standard error. Data source = Breast invasive carcinoma TCGA. ( I-K ) Spearman’s Correlation of Metastatic burden signature correlated to FAK-dependent ECM score (I ), COL8A1 ( J ) and LAMA5 ( K ) expression in triple negative breast cancer patients of the SCAN-B dataset . Spearman’s correlation of cytotoxic CD8 + T cells with COL8A1 ( L ) and LAMA5 ( M ) expression in triple negative breast cancer patients of the SCAN-B dataset. ( L & M ). Log 2 mRNA abundance of COL8A1 and LAMA5 in triple negative breast cancer patients with complete response (pCR) or residual disease (RD) in biopsies taken before treatment with either Palclitaxel and Pembrolizumab ( O ) or Palclitaxel, ABT888 and Carboplatin ( N ) in ISPY-2 trial.
Laminin, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/laminin/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
laminin - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

97
AMS Biotechnology recombinant laminin 511 e8
Mice bearing Cer2-OVA MMTV-PyMT lung metastases were treated with vehicle (0.5% HPMC) or 75 mg/kg VS-4718 p.o. for 2 weeks starting 4 weeks post-implantation. ( A & B ) Representative images and quantification of collagen VIIIα1 and <t>laminin</t> 5α in metastatic versus non-metastatic lung regions at 6 weeks (H-score; each dot represents one lesion; n = <t>5</t> mice/group). Kruskal-Wallis test and Dunn’s multiple comparison. ( C & D ) Collagen VIIIα1 and laminin 511 suppress CD8⁺ T cell activation in vitro . CD8⁺ T cells were plated on 1 μg/mL ECM components, stimulated with CD3/CD28 + IL-2 for 48 h, and assessed by flow cytometry for CD25, granzyme B, IFNγ, and TNFα expression (n = 3-5). ( E ) ECM-mediated inhibition of CD8⁺ T cell migration. Transwell inserts coated with laminin 511, or collagen VIIIα were used to assess migration toward serum-rich media for 5 h (n = 3-4). ( F ) ECM-dependent CD8⁺ T cell adhesion. Adhesion to laminin 511, or collagen VIIIα-coated plates was quantified after 90 min and normalized to uncoated plates (n = 3-4). (G & H) Kaplan-Meier curves showing progression-free survival (PFS) of patients with invasive breast carcinoma stratified by (G) COL8A1 and (H) LAMA5 expression levels. Patients were divided into high and low expression groups based on the median RNA-seq expression. Point-wise z-test using Greenwood’s standard error. Data source = Breast invasive carcinoma TCGA. ( I-K ) Spearman’s Correlation of Metastatic burden signature correlated to FAK-dependent ECM score (I ), COL8A1 ( J ) and LAMA5 ( K ) expression in triple negative breast cancer patients of the SCAN-B dataset . Spearman’s correlation of cytotoxic CD8 + T cells with COL8A1 ( L ) and LAMA5 ( M ) expression in triple negative breast cancer patients of the SCAN-B dataset. ( L & M ). Log 2 mRNA abundance of COL8A1 and LAMA5 in triple negative breast cancer patients with complete response (pCR) or residual disease (RD) in biopsies taken before treatment with either Palclitaxel and Pembrolizumab ( O ) or Palclitaxel, ABT888 and Carboplatin ( N ) in ISPY-2 trial.
Recombinant Laminin 511 E8, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant laminin 511 e8/product/AMS Biotechnology
Average 97 stars, based on 1 article reviews
recombinant laminin 511 e8 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

90
Biosynth Carbosynth biotin
Mice bearing Cer2-OVA MMTV-PyMT lung metastases were treated with vehicle (0.5% HPMC) or 75 mg/kg VS-4718 p.o. for 2 weeks starting 4 weeks post-implantation. ( A & B ) Representative images and quantification of collagen VIIIα1 and <t>laminin</t> 5α in metastatic versus non-metastatic lung regions at 6 weeks (H-score; each dot represents one lesion; n = <t>5</t> mice/group). Kruskal-Wallis test and Dunn’s multiple comparison. ( C & D ) Collagen VIIIα1 and laminin 511 suppress CD8⁺ T cell activation in vitro . CD8⁺ T cells were plated on 1 μg/mL ECM components, stimulated with CD3/CD28 + IL-2 for 48 h, and assessed by flow cytometry for CD25, granzyme B, IFNγ, and TNFα expression (n = 3-5). ( E ) ECM-mediated inhibition of CD8⁺ T cell migration. Transwell inserts coated with laminin 511, or collagen VIIIα were used to assess migration toward serum-rich media for 5 h (n = 3-4). ( F ) ECM-dependent CD8⁺ T cell adhesion. Adhesion to laminin 511, or collagen VIIIα-coated plates was quantified after 90 min and normalized to uncoated plates (n = 3-4). (G & H) Kaplan-Meier curves showing progression-free survival (PFS) of patients with invasive breast carcinoma stratified by (G) COL8A1 and (H) LAMA5 expression levels. Patients were divided into high and low expression groups based on the median RNA-seq expression. Point-wise z-test using Greenwood’s standard error. Data source = Breast invasive carcinoma TCGA. ( I-K ) Spearman’s Correlation of Metastatic burden signature correlated to FAK-dependent ECM score (I ), COL8A1 ( J ) and LAMA5 ( K ) expression in triple negative breast cancer patients of the SCAN-B dataset . Spearman’s correlation of cytotoxic CD8 + T cells with COL8A1 ( L ) and LAMA5 ( M ) expression in triple negative breast cancer patients of the SCAN-B dataset. ( L & M ). Log 2 mRNA abundance of COL8A1 and LAMA5 in triple negative breast cancer patients with complete response (pCR) or residual disease (RD) in biopsies taken before treatment with either Palclitaxel and Pembrolizumab ( O ) or Palclitaxel, ABT888 and Carboplatin ( N ) in ISPY-2 trial.
Biotin, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotin/product/Biosynth Carbosynth
Average 90 stars, based on 1 article reviews
biotin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Figure 5. Human PDLSCs cultured on TEST titanium implant surface were observed after 8 weeks of incubation. Cytoskeleton actin was stained in red fluorescence; specific markers (A) Fibronectin. This picture was taken from the paper published [14]. (B) Laminin, (C) N-cadherin and (D) RUNX2, were stained in green fluorescence; nuclei were stained in blue fluorescence. Scale bar: 10 µm.

Journal: Biology

Article Title: Human Periodontal Ligament Stem Cells Response to Titanium Implant Surface: Extracellular Matrix Deposition.

doi: 10.3390/biology10090931

Figure Lengend Snippet: Figure 5. Human PDLSCs cultured on TEST titanium implant surface were observed after 8 weeks of incubation. Cytoskeleton actin was stained in red fluorescence; specific markers (A) Fibronectin. This picture was taken from the paper published [14]. (B) Laminin, (C) N-cadherin and (D) RUNX2, were stained in green fluorescence; nuclei were stained in blue fluorescence. Scale bar: 10 µm.

Article Snippet: Primary monoclonal antibodies to anti-human Fibronectin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), Laminin (Santa Cruz Biotechnology), N-Cadherin (Santa Cruz Biotechnology) and RUNX2 (Santa Cruz Biotechnology) were utilized, followed by Alexa Fluor 488 green fluorescence conjugated goat anti-mouse as secondary antibodies (Molecular Probes, Invitrogen, Eugene, OR, USA).

Techniques: Cell Culture, Incubation, Staining

Figure 4. Human PDLSCs cultured on CTRL titanium implant surface were observed after 8 weeks of culture. Cytoskeleton actin was stained in red fluorescence; specific markers (A) Fibronectin, (B) Laminin, (C) N-cadherin and (D) RUNX2, were stained in green fluorescence; nuclei were stained in blue fluorescence. This picture was taken from the paper published [14]. Scale bar: 10 µm.

Journal: Biology

Article Title: Human Periodontal Ligament Stem Cells Response to Titanium Implant Surface: Extracellular Matrix Deposition.

doi: 10.3390/biology10090931

Figure Lengend Snippet: Figure 4. Human PDLSCs cultured on CTRL titanium implant surface were observed after 8 weeks of culture. Cytoskeleton actin was stained in red fluorescence; specific markers (A) Fibronectin, (B) Laminin, (C) N-cadherin and (D) RUNX2, were stained in green fluorescence; nuclei were stained in blue fluorescence. This picture was taken from the paper published [14]. Scale bar: 10 µm.

Article Snippet: Primary monoclonal antibodies to anti-human Fibronectin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), Laminin (Santa Cruz Biotechnology), N-Cadherin (Santa Cruz Biotechnology) and RUNX2 (Santa Cruz Biotechnology) were utilized, followed by Alexa Fluor 488 green fluorescence conjugated goat anti-mouse as secondary antibodies (Molecular Probes, Invitrogen, Eugene, OR, USA).

Techniques: Cell Culture, Staining

Figure 6. (A) Graph of RT-PCR showed the mRNA levels of RUNX2, ALP, VIM, FN1, CDH2, LAMB1, FAK and ITGB1 in cells cultured on CTRL and TEST surface. * p < 0.05; ** p < 0.01. (B) Protein level expression of Fibronectin, Laminin, N-cadherin and RUNX2 in cells cultured on CTRL and TEST surface. β-actin was used as a housekeeping protein. Graph bars represent the densitometric measurements of proteins bands expressed as integrated optical intensity with the mean of three separate experiments. The error bars in these graphs showed the standard deviation (±SD). Densitometric values analysed by ANOVA showed significant differences. ** p < 0.01; *** p < 0.001. Please refer to Full Western blot in Supplementary.

Journal: Biology

Article Title: Human Periodontal Ligament Stem Cells Response to Titanium Implant Surface: Extracellular Matrix Deposition.

doi: 10.3390/biology10090931

Figure Lengend Snippet: Figure 6. (A) Graph of RT-PCR showed the mRNA levels of RUNX2, ALP, VIM, FN1, CDH2, LAMB1, FAK and ITGB1 in cells cultured on CTRL and TEST surface. * p < 0.05; ** p < 0.01. (B) Protein level expression of Fibronectin, Laminin, N-cadherin and RUNX2 in cells cultured on CTRL and TEST surface. β-actin was used as a housekeeping protein. Graph bars represent the densitometric measurements of proteins bands expressed as integrated optical intensity with the mean of three separate experiments. The error bars in these graphs showed the standard deviation (±SD). Densitometric values analysed by ANOVA showed significant differences. ** p < 0.01; *** p < 0.001. Please refer to Full Western blot in Supplementary.

Article Snippet: Primary monoclonal antibodies to anti-human Fibronectin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), Laminin (Santa Cruz Biotechnology), N-Cadherin (Santa Cruz Biotechnology) and RUNX2 (Santa Cruz Biotechnology) were utilized, followed by Alexa Fluor 488 green fluorescence conjugated goat anti-mouse as secondary antibodies (Molecular Probes, Invitrogen, Eugene, OR, USA).

Techniques: Reverse Transcription Polymerase Chain Reaction, Cell Culture, Expressing, Standard Deviation, Western Blot

Mice bearing Cer2-OVA MMTV-PyMT lung metastases were treated with vehicle (0.5% HPMC) or 75 mg/kg VS-4718 p.o. for 2 weeks starting 4 weeks post-implantation. ( A & B ) Representative images and quantification of collagen VIIIα1 and laminin 5α in metastatic versus non-metastatic lung regions at 6 weeks (H-score; each dot represents one lesion; n = 5 mice/group). Kruskal-Wallis test and Dunn’s multiple comparison. ( C & D ) Collagen VIIIα1 and laminin 511 suppress CD8⁺ T cell activation in vitro . CD8⁺ T cells were plated on 1 μg/mL ECM components, stimulated with CD3/CD28 + IL-2 for 48 h, and assessed by flow cytometry for CD25, granzyme B, IFNγ, and TNFα expression (n = 3-5). ( E ) ECM-mediated inhibition of CD8⁺ T cell migration. Transwell inserts coated with laminin 511, or collagen VIIIα were used to assess migration toward serum-rich media for 5 h (n = 3-4). ( F ) ECM-dependent CD8⁺ T cell adhesion. Adhesion to laminin 511, or collagen VIIIα-coated plates was quantified after 90 min and normalized to uncoated plates (n = 3-4). (G & H) Kaplan-Meier curves showing progression-free survival (PFS) of patients with invasive breast carcinoma stratified by (G) COL8A1 and (H) LAMA5 expression levels. Patients were divided into high and low expression groups based on the median RNA-seq expression. Point-wise z-test using Greenwood’s standard error. Data source = Breast invasive carcinoma TCGA. ( I-K ) Spearman’s Correlation of Metastatic burden signature correlated to FAK-dependent ECM score (I ), COL8A1 ( J ) and LAMA5 ( K ) expression in triple negative breast cancer patients of the SCAN-B dataset . Spearman’s correlation of cytotoxic CD8 + T cells with COL8A1 ( L ) and LAMA5 ( M ) expression in triple negative breast cancer patients of the SCAN-B dataset. ( L & M ). Log 2 mRNA abundance of COL8A1 and LAMA5 in triple negative breast cancer patients with complete response (pCR) or residual disease (RD) in biopsies taken before treatment with either Palclitaxel and Pembrolizumab ( O ) or Palclitaxel, ABT888 and Carboplatin ( N ) in ISPY-2 trial.

Journal: bioRxiv

Article Title: FAK Inhibition Remodels the Metastatic ECM and Restores CD8⁺ T Cell Trafficking and Immunosurveillance

doi: 10.64898/2026.01.21.700837

Figure Lengend Snippet: Mice bearing Cer2-OVA MMTV-PyMT lung metastases were treated with vehicle (0.5% HPMC) or 75 mg/kg VS-4718 p.o. for 2 weeks starting 4 weeks post-implantation. ( A & B ) Representative images and quantification of collagen VIIIα1 and laminin 5α in metastatic versus non-metastatic lung regions at 6 weeks (H-score; each dot represents one lesion; n = 5 mice/group). Kruskal-Wallis test and Dunn’s multiple comparison. ( C & D ) Collagen VIIIα1 and laminin 511 suppress CD8⁺ T cell activation in vitro . CD8⁺ T cells were plated on 1 μg/mL ECM components, stimulated with CD3/CD28 + IL-2 for 48 h, and assessed by flow cytometry for CD25, granzyme B, IFNγ, and TNFα expression (n = 3-5). ( E ) ECM-mediated inhibition of CD8⁺ T cell migration. Transwell inserts coated with laminin 511, or collagen VIIIα were used to assess migration toward serum-rich media for 5 h (n = 3-4). ( F ) ECM-dependent CD8⁺ T cell adhesion. Adhesion to laminin 511, or collagen VIIIα-coated plates was quantified after 90 min and normalized to uncoated plates (n = 3-4). (G & H) Kaplan-Meier curves showing progression-free survival (PFS) of patients with invasive breast carcinoma stratified by (G) COL8A1 and (H) LAMA5 expression levels. Patients were divided into high and low expression groups based on the median RNA-seq expression. Point-wise z-test using Greenwood’s standard error. Data source = Breast invasive carcinoma TCGA. ( I-K ) Spearman’s Correlation of Metastatic burden signature correlated to FAK-dependent ECM score (I ), COL8A1 ( J ) and LAMA5 ( K ) expression in triple negative breast cancer patients of the SCAN-B dataset . Spearman’s correlation of cytotoxic CD8 + T cells with COL8A1 ( L ) and LAMA5 ( M ) expression in triple negative breast cancer patients of the SCAN-B dataset. ( L & M ). Log 2 mRNA abundance of COL8A1 and LAMA5 in triple negative breast cancer patients with complete response (pCR) or residual disease (RD) in biopsies taken before treatment with either Palclitaxel and Pembrolizumab ( O ) or Palclitaxel, ABT888 and Carboplatin ( N ) in ISPY-2 trial.

Article Snippet: Slides were incubated overnight at 4 °C with primary antibodies against laminin α5 (polyclonal, Bioss, Cat# BS-1086R, 1:500) or collagen VIIIα1 (rabbit polyclonal, Abcam, Cat# ab236653, 1:300) diluted in antibody diluent.

Techniques: Comparison, Activation Assay, In Vitro, Flow Cytometry, Expressing, Inhibition, Migration, RNA Sequencing

Mice carrying Cer2-OVA MMTV-PyMT metastatic lesions or without Cer2-OVA MMTV-PyMT injection were treated for two weeks with either vehicle control (0.5% HPMC) or VS-4718 (75 mg/kg). Quantification (H-score) of concentration of (A) Collagen VIIIα1 and (B) Laminin 5α in metastatic lesions and tumor adjacent areas at 5 weeks post implantation of Cer2-OVA MMTV-PyMT cells. Each dot represents a metastatic lesion. n = 5 mice/group using whole lung slide scans. One-way ANOVA for normal distributed with Tukey’s multiple comparison test. Mean ± SEM; ** = p < 0.01.

Journal: bioRxiv

Article Title: FAK Inhibition Remodels the Metastatic ECM and Restores CD8⁺ T Cell Trafficking and Immunosurveillance

doi: 10.64898/2026.01.21.700837

Figure Lengend Snippet: Mice carrying Cer2-OVA MMTV-PyMT metastatic lesions or without Cer2-OVA MMTV-PyMT injection were treated for two weeks with either vehicle control (0.5% HPMC) or VS-4718 (75 mg/kg). Quantification (H-score) of concentration of (A) Collagen VIIIα1 and (B) Laminin 5α in metastatic lesions and tumor adjacent areas at 5 weeks post implantation of Cer2-OVA MMTV-PyMT cells. Each dot represents a metastatic lesion. n = 5 mice/group using whole lung slide scans. One-way ANOVA for normal distributed with Tukey’s multiple comparison test. Mean ± SEM; ** = p < 0.01.

Article Snippet: Slides were incubated overnight at 4 °C with primary antibodies against laminin α5 (polyclonal, Bioss, Cat# BS-1086R, 1:500) or collagen VIIIα1 (rabbit polyclonal, Abcam, Cat# ab236653, 1:300) diluted in antibody diluent.

Techniques: Injection, Control, Concentration Assay, Comparison

(A) Representative images of collagen VIIIα1 in metastatic lesions. Scalebar = 50 μm. (B) Quantification (H-score) of collagen VIIIα1 in metastatic lesions and tumor adjacent areas. (C) Representative images of laminin 5 α in metastatic lesions and tumor adjacent areas. Scalebar = 50 μm. (D) Quantification (H-score) of laminin 5 α in metastatic lesions and tumor adjacent areas. Dots represent metastatic lesions. n = 5 mice/group using whole lung slide scans. Kruskal-Wallis test and Dunn’s multiple comparison for not normal distributed. Mean ± SEM; **** = p < 0.0001.

Journal: bioRxiv

Article Title: FAK Inhibition Remodels the Metastatic ECM and Restores CD8⁺ T Cell Trafficking and Immunosurveillance

doi: 10.64898/2026.01.21.700837

Figure Lengend Snippet: (A) Representative images of collagen VIIIα1 in metastatic lesions. Scalebar = 50 μm. (B) Quantification (H-score) of collagen VIIIα1 in metastatic lesions and tumor adjacent areas. (C) Representative images of laminin 5 α in metastatic lesions and tumor adjacent areas. Scalebar = 50 μm. (D) Quantification (H-score) of laminin 5 α in metastatic lesions and tumor adjacent areas. Dots represent metastatic lesions. n = 5 mice/group using whole lung slide scans. Kruskal-Wallis test and Dunn’s multiple comparison for not normal distributed. Mean ± SEM; **** = p < 0.0001.

Article Snippet: Slides were incubated overnight at 4 °C with primary antibodies against laminin α5 (polyclonal, Bioss, Cat# BS-1086R, 1:500) or collagen VIIIα1 (rabbit polyclonal, Abcam, Cat# ab236653, 1:300) diluted in antibody diluent.

Techniques: Comparison

(A) Mean migration velocity and (B) directional change rate/ average turning frequency of activated CD8⁺ T cells migrating on laminin 511 or collagen VIIIα1 (1 µg/cm²). T cells were CellTracker™ Deep Red-labeled and imaged for 6 h at 5-min intervals; tracks with >11 spots were analyzed using TrackMate . Laminin-511 reduced velocity and increased turning frequency, whereas collagen VIIIα1 had no significant effect. n = 3 independent experiments with 3-5 field of views per group. Unpaired t-tests. Mean ± SEM; **** = p < 0.0001.

Journal: bioRxiv

Article Title: FAK Inhibition Remodels the Metastatic ECM and Restores CD8⁺ T Cell Trafficking and Immunosurveillance

doi: 10.64898/2026.01.21.700837

Figure Lengend Snippet: (A) Mean migration velocity and (B) directional change rate/ average turning frequency of activated CD8⁺ T cells migrating on laminin 511 or collagen VIIIα1 (1 µg/cm²). T cells were CellTracker™ Deep Red-labeled and imaged for 6 h at 5-min intervals; tracks with >11 spots were analyzed using TrackMate . Laminin-511 reduced velocity and increased turning frequency, whereas collagen VIIIα1 had no significant effect. n = 3 independent experiments with 3-5 field of views per group. Unpaired t-tests. Mean ± SEM; **** = p < 0.0001.

Article Snippet: Slides were incubated overnight at 4 °C with primary antibodies against laminin α5 (polyclonal, Bioss, Cat# BS-1086R, 1:500) or collagen VIIIα1 (rabbit polyclonal, Abcam, Cat# ab236653, 1:300) diluted in antibody diluent.

Techniques: Migration, Labeling

FAK inhibition reduces laminin-α5 and collagen VIIIα1 within metastatic lesions, weakening basement-membrane-derived physical and inhibitory barriers, thereby improving CD8⁺ T-cell infiltration, migration, tumor-cell engagement, and cytotoxic activity to promote metastatic regression.

Journal: bioRxiv

Article Title: FAK Inhibition Remodels the Metastatic ECM and Restores CD8⁺ T Cell Trafficking and Immunosurveillance

doi: 10.64898/2026.01.21.700837

Figure Lengend Snippet: FAK inhibition reduces laminin-α5 and collagen VIIIα1 within metastatic lesions, weakening basement-membrane-derived physical and inhibitory barriers, thereby improving CD8⁺ T-cell infiltration, migration, tumor-cell engagement, and cytotoxic activity to promote metastatic regression.

Article Snippet: Slides were incubated overnight at 4 °C with primary antibodies against laminin α5 (polyclonal, Bioss, Cat# BS-1086R, 1:500) or collagen VIIIα1 (rabbit polyclonal, Abcam, Cat# ab236653, 1:300) diluted in antibody diluent.

Techniques: Inhibition, Membrane, Derivative Assay, Migration, Activity Assay